EXAS

NASDAQ

EXACT Sciences Corp. · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$20.03B

PE Ratio

—

EV to Ebitda

323.4291

Earnings Yield

-1.07%

Revenue (TTM)

$3.25B

Net Income (TTM)

$-207.9M

Revenue (Annual YoY Growth)

17.69%

Revenue (Quarterly YoY Growth)

23.12%

Profit Margin

-6.40%

Return on Equity

-8.54%

Debt to Equity Ratio

1.0557

Dividend Yield

0.00%

All fundamentals

Core11 fields›

Market Cap$20.03B

Revenue TTM$3.25B

Shares Outstanding190.9M

Float179645982

Float Short3.52%

Days To Cover2.7986092887

Short Interest6649744.0

Insider Ownership3.06%

Volume486553

Relative Strength97.6

GARP2434

Growth Estimates16 fields›

Revenue Growth (Annual)17.69%

Revenue Growth (Quarterly YoY)23.12%

Operating Revenue Growth (Annual)0.257814

Operating Revenue Growth (Quarterly YoY)0.160088

3-Year Revenue Growth15.92%

5-Year Revenue Growth16.84%

EPS Growth (Annual)80.27%

EPS Growth (Quarterly YoY)90.29%

3-Year EPS Growth Rate0.00%

5-Year EPS Growth Rate0.00%

EBITDA Growth (Annual)430.97%

EBITDA Growth (Quarterly YoY)-278.72%

CFO Growth (Annual)133.42%

CFO Growth (Quarterly YoY)222.31%

FCF Growth (Annual)378.60%

FCF Growth (Quarterly YoY)116.06%

Operations28 fields›

Revenue TTM$3.25B

Gross Margin TTM69.69%

Gross Margin (Quarterly)70.11%

R&D % of Revenue TTM16.10%

R&D Expenses TTM$522.9M

Operating Margin TTM-4.79%

Operating Margin (Quarterly)-8.73%

Operating Expenses TTM$2.42B

Profit Margin TTM-6.40%

Profit Margin (Quarterly)-9.79%

Net Income TTM$-207.9M

EPS TTM-1.1046

EPS (Quarterly)-0.453

EBIT Margin TTM-4.79%

EBIT Margin (Quarterly)-8.73%

EBITDA Margin TTM2.03%

EBITDA Margin (Quarterly)-2.31%

EBITDA TTM$65.9M

CFO % of Revenue TTM15.14%

CFO % of Revenue (Quarterly)17.27%

CFO TTM$491.4M

Cash Margin12.08%

Capex % of Revenue TTM4.15%

Capital Expenditures$134.7M

FCF % of Revenue TTM10.99%

FCF % of Revenue (Quarterly)13.71%

FCF TTM$356.8M

Fundamental Score6

Efficiency6 fields›

ROE-8.54%

ROA-3.50%

ROIC-4.14%

CROCI7.11%

Stock Comp % (Quarterly)6.33%

Stock Comp % TTM6.70%

Valuation16 fields›

P/E Forward91.1278

P/S Forward5.3864

P/CFO39.7101

P/FCF54.6974

EV/EBITDA (TTM)323.4291

EV/EBITDA Forward34.4738

EV/Revenues (TTM)6.5641

EV/Revenues Forward5.8147

EV/CFO42.6259

EV/FCF (TTM)59.7386

Price To Book8.2229

Price to Tangible Book-8.1581

Earnings Yield-1.07%

FCF Yield1.83%

Dividend Yield0.00%

Value Score1

Relative to Industry5 fields›

Relative Gross Margin (Quarterly)1.6746

Relative P/S1.4277

Relative P/B2.1778

Relative Dividend Yield0

Relative Debt to Equity1.7479

Liquidity15 fields›

Cash Per Share5.0561

Current Ratio2.4266

Cash & ST Assets$964.7M

Total Debt$2.50B

Goodwill & Intangibles$3.29B

Total Assets$6.08B

Total Liabilities$3.68B

Shareholders Equity$2.40B

Debt to Equity1.0557

Debt to Assets41.66%

Interest Expense$37.6M

Times Interest Earned-4.1361

CFO to Debt (TTM)0.1902

Debt to EBITDA (TTM)39.2163

Goodwill % of Assets54.04%

Yields4 fields›

Dividend Yield0.00%

Earnings Yield-1.07%

Buyback Yield-0.14%

Shareholder Yield0.11%

Options Flow8 fields›

Call Volume0

Put Volume0

Put/Call Ratio0

Call $ Volume0

Put $ Volume0

Put/Call $ Ratio0

Call OI31561

Put OI15380